New anesthesia combo may speed recovery after day surgery

NCT ID NCT07663877

Not yet recruiting Symptom relief Sponsor: Chung-Ang University Gwangmyeong Hospital Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether using a short-acting sedative (remimazolam) followed by a reversal drug (flumazenil) can help women wake up faster after hysteroscopic day surgery compared to standard anesthesia. About 124 adult women will be randomly assigned to one of the two methods. The main goal is to see if the new approach shortens the time from starting anesthesia to being ready for discharge, while keeping recovery safe and comfortable.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Remimazolam (a short-acting sedative) and flumazenil (a reversal agent)
What this could lead to: If successful, this approach could help patients wake up faster after day surgery and allow hospitals to run more efficiently.
What could go wrong: This is a small, early-phase trial (124 participants) comparing two anesthesia methods, not testing a new treatment. The results may not apply to other surgeries or patient groups.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AMBULATORY SURGERY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

AMBULATORY SURGERY GENERAL ANESTHESIA HYSTEROSCOPY

Contacts and locations

Locations

Chung-Ang University Gwangmyeong Hospital

Gwangmyeong, Gyeonggi-do, 14353, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.